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Abstract
Human papillomavirus (HPV) is the most prevalent sexually-transmitted infection in the 
U.S. Specific types have been linked to 70% of cervical cancers, 90% of genital warts, 
65% of vulvar cancers, 35% of penile cancers, and 70% of head and neck cancers 
(Markowitz et al., 2014). According to the CDC, the most effective way to prevent HPV- 
associated infections and HPV-related cancer is through vaccination. The purpose of this 
study was to determine how knowledgeable college students ages 18-26 years are of 
HPV, HPV vaccine, and vaccination compliance among these students. The Health 
Promotion Model (HPM) created by Pender (2011) was used as the theoretical 
framework for guiding this study. This research study presented the following questions:
V
Are college students ages 18-26 years knowledgeable of HPV and HPV-related diseases? 
Are college students ages 18-26 years knowledgeable of the HPV vaccination series? Are 
college students initiating the HPV vaccination series? The study was a nonexperimental, 
quantitative study that used descriptive statistics. A convenience sample of 30 college 
students ages 18-26 years that signed in at a university student health center and 
completed a 30-question survey that was used to assess the desired variables. Knowledge 
of HPV was assessed by 24 true and false questions related to HPV disease. A score of 0 
was given for each incorrect answer, and a score of 1 was given for each correct answer 
with a total of 24 points possible. College students with a total score of 17 points or 
higher were considered knowledgeable of HPV. Knowledge of the HPV vaccine was 
assessed by 6 questions related to the HPV vaccine. A score of 0 was given for each 
incorrect answer, and a score of 1 was given for each correct answer with a total of 6 
points possible. College students with a total score of 5 or higher were considered 
knowledgeable of the HPV vaccine. Results of the three research questions are as 
follows. In response to Question 1, whether college students ages 18-26 years are 
knowledgeable of the HPV-related diseases, 18 participants received a passing grade on 
the HPV questions (60% passing rate), and 12 participants received a failing grade (40% 
failure rate). In response to Question 2, whether college students ages 18-26 years are 
knowledgeable of the HPV vaccination series, 66.7% had a passing rate and 33.3% had a 
failing rate. In response to Question 3 (whether college students are initiating HPV 
series), 43.3% indicated that they had taken the HPV vaccination, 50.0% indicated that 
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CHAPTER I 
Dimensions of the Problem
Background of Problem
The human papillomavirus (HPV) is a group of more than 150 related viruses. In 
most cases, HPV goes away on its own and does not cause any health problems. But 
when HPV does not go away, it can cause health problems such as genital warts and 
cancer (Centers for Disease Control and Prevention [CDC], 2015a). Certain HPV types 
are the cause of genital warts, cancers of the female and male sex organs, and cancers of 
the oropharynx. Specifically, HPV types 16 and 18 are responsible for an estimated 70% 
of cervical cancers, and HPV types 6 and 11 are related to 90% of genital warts (CDC, 
2015a). HPV type 16 is linked to 90% of anal cancers, 65% of vulvar cancers, 35% of 
penile cancers, and 70% of head and neck cancers (Jorge & Wright, 2016). Every year in 
the U.S. 27,000 people have cancer caused by HPV—one person every 20 minutes of 
every day all year long—making HPV the most common sexually-transmitted infection 
("HPV Prevention Handouts," 2015). At some time in his or her life, the HPV virus 
infects at least 50% of all people who are sexually active (CDC, 2015b). It is estimated 
that the lifetime prevalence of HPV in both men and women by age 45 years is 80-90% 
(Jorge & Wright, 2016; Markowitz et al., 2014). Approximately 80 million people in the 
U.S. have HPV, and 14 million people aged 15-59 years are diagnosed each year (Schub, 
2016). An analysis of data from the National Health and Nutrition Examination Survey 
(2003-2006) reported that HPV infection in the U.S. was highest in females ages 20-24 
years, with an overall prevalence of 18.5% among females in this age category (Dunne et 
al., 2011).
The prevention of HPV has been a public health priority over the past 10 years. 
The most effective way to prevent HPV-associated infections and HPV-related cancer is 
through vaccination (CDC, 2015a). In 2006, the Food and Drug Administration (FDA) 
approved a quadrivalent HPV vaccine (Gardasil manufactured by Merck). In 2007, the 
Advisory Committee on Immunization Practices (ACIP) recommended the vaccine for 
females ages 9-26 years (Markowitz et al., 2007). Later, in 2011, the same 
recommendations were made for males ages 9-26 years. Ideally, the vaccine should be 
administered before potential exposure to HPV through sexual contact. The HPV 
vaccine has demonstrated safety and nearly 100% efficacy in protecting against HPV 
types 16 and 18, responsible for cervical cancers and HPV types 6 and 11, and 
responsible for genital warts (Schub, 2016). In December 2014, the FDA approved 
Gardasil 9 for the prevention of certain diseases caused by HPV. Gardasil 9 protects 
against HPV types 16, 18, 31, 33, 45, 52, and 58 that are linked to certain cancers and 
HPV types 6 and 11 for the prevention of genital warts (Petrosky et al., 2015). In May of 
2017, when the last doses of quadrivalent HPV expired, Gardasil 9 is the only HPV 
vaccine available in the U.S. (Meites, Kemp, & Markowitz, 2016). With the ACIP 
vaccination recommendations, the goal is to reduce the number of men and women 
infected with HPV— subsequently preventing HPV causing cancers and associated 
diseases.
As with many immunizations, there are barriers to compliance and follow through 
of the HPV vaccination series. These barriers include, but are not limited to, knowledge 
deficit or lack of information of HPV and its long-term effects, financial constraints, 
medical insurance coverage issues, parental attitudes toward the vaccine, a lower 
perceived risk of HPV infections, and a lack of information provided as to who and how
the vaccine benefits both males and females. Many in the reeommended age group are 
not yet seeing a physician on a regular basis so irregular preventative care is also a barrier 
(Lawrence, Gootman, & Sim, 2009). There are some cases where individuals have not 
received all doses of the vaccination. While the incomplete series does provide a small 
amount of immunity, it is still important to undergo all doses in the recommended series 
of the vaccine in order to receive the most effective benefit (CDC, 2016a). The ACIP 
recommends a 2-dose schedule for girls and boys who initiate the vaccination series at 
ages 9-14 years. Three doses are recommended for persons who initiate the vaccination 
series at ages 15-26 years and for immunocompromised persons (CDC, 2015b).
The HPV virus is transmitted through direct skin-to-skin contact. Although 
infection is most often spread through penetrative vaginal or anal intercourse, other types 
of sexual contact can transmit HPV. Infection has been reported in self-reported 
“virgins” (Winer et al., 2014). Most HPV infections are acquired within the first years of 
sexual activity as demonstrated by a study of 82 female college students in which it was 
found that approximately 40% of HPV infections are acquired within 2 years of the first 
sexual experience (Winer et al., 2014). The risk of infection is proportionately related to 
the number of sexual partners, which has been demonstrated in studies conducted by the 
CDC, National Institutes of Health, and an individual study on Behavioral Perceptions of 
Oakland University Female College Students towards Human Papillomavirus 
Vaccination (Navalpakam, Dany, & Hussein, 2016). Since many college students are 
sexually active (75-90%) and report an average of > 2 partners per year, they are at a 
unique risk for HPV infection (Daley et al., 2010). Despite the immunization 
recommendations by the ACIP, the college-aged cohort has demonstrated low 
compliance with the HPV vaccination series (Daley et al., 2010). Reports indicate that
only 9-10% of women aged 18-26 years have initiated the HPV vaccine schedule (Patel 
et al., 2012). These data demonstrate the importance of HPV education and catch-up 
vaccination among this age group.
Purpose of the Research Study
HPV is the most common sexually-transmitted infection in the U.S. with more 
than 40 different strands that infect the genital tract. Several of these strands are known 
to cause cancer and genital warts. The most effective way to prevent HPV-associated 
infections and HPV-related cancer is through vaccination (CDC, 2015a). A quadrivalent 
vaccine was approved and made available for females ages 9-26 years in 2006 and for 
males in 2011. In December 2014, a 9-valent vaccine was approved for males and 
females ages 9-26 years. The purpose of this research study was to determine how 
knowledgeable college students, ages 18-26 years, were of the HPV and the HPV vaccine 
as well as vaccination compliance among these students.
Significance to Nursing
Researching college students’ knowledge regarding HPV and the available 
vaccination is beneficial to the medical profession. Advanced practice nurses have an 
ethical obligation and professional responsibility to promote healthy lifestyles, wellness 
maintenance, and illness prevention. With a better understanding of what factors can put 
certain populations at a disadvantage, nursing professionals can then provide these 
patients with accurate information and direction on promoting healthy lifestyles based on 
their personal health behaviors.
Education of the patient and conununity is an essential duty of the nurse. The 
information obtained in this study will aid nurses in the student health center to develop 
specific strategies for educating students on HPV and the HPV vaccine on campus. It
may also be useful for nurses planning educational campaigns at other college campus 
health centers, local health departments, or private clinics.
Significance to Research
HPV is the most prevalent sexually-transmitted infection, and college students are 
one of the most at-risk populations (CDC, 2015b). The HPV vaccine protects against the 
HPV subtypes responsible for causing genital warts and cervical cancer, and some penile, 
anal, oropharyngeal and vulvar cancers (CDC, 2015a). However, previous studies have 
reported vaccine uptake as low as 9-10% and as high as 43% in college-aged women 
(Licht et al., 2010). The current study added to the body of research already collected on 
this highest risk group, particularly the very limited research in men of this age. 
Assessment of current vaccination rate and variables studied allows for comparison of 
findings among age groups, gender, insurance status, and ethnicity. This comparison can 
help determine the success of educational efforts and vaccine campaigns or help to 
determine areas needed for further study and intervention. For preventable disease to be 
completely prevented, public awareness and health literacy are essential. The 
information collected in this study can play a valuable role in developing and improving 
interventions that increase vaccination rates in both women and men. Correlates of HPV 
knowledge and vaccination status can support findings of previous studies or identify 
differences from previous study findings and provide topics for further research. 
Significance to Education
HPV is a very common virus, and nearly all men and women get it at some point 
in their lives. Every year in the U.S., HPV causes 30,700 cancers in men and women. 
HPV vaccination can prevent most of the cancers (about 28,000) from occurring. The 
HPV vaccine could prevent most caneers and other diseases caused by HPV (Meites et
al., 2016). The purpose of this research study was to determine how knowledgeable 
college students, ages 18-26 years, were of HPV and the HPV vaccine as well as 
compliance among these students. College students represent an at-risk population for 
HPV infection. A study by Patel et al. (2013) supports the high acceptance rate (68.8% 
to 76.3%) of HPV vaccine acceptability conducted among young adult females and 
males, specifically college-aged individuals. However, despite the generally high levels 
of HPV vaccine acceptability among young adults, vaccine uptake in this population 
remains low.
Education is an essential duty of the primary care provider and is needed to 
increase the HPV vaccination uptake rate. Primary care providers use education as a tool 
to convey pertinent information to patients regarding health and health maintenance and 
are uniquely positioned to increase the awareness of the benefits of undergoing the HPV 
vaccination. The current research will assist in the education of primary care providers 
and the general public on the significance of the HPV vaccination in preventing the HPV 
virus and the cancers associated with it. While knowledge alone may not produce the 
desired effect of increased vaccination rates, it is an important first step toward adopting 
any healthy behavior. This study contributed to education by assessing college students’ 
knowledge of HPV and the HPV vaccine and identifying trends among the demographic 
variables. The study findings can identify both target topics and target populations for 
education campaigns aimed at improving vaccination.
Conceptual Framework
The Health Promotion Model was used as a basis for this study as the researchers 
studied the college students’ knowledge of the HPV, the HPV vaccine, and their 
compliance with the vaccine. Pender (2011) developed the Health Promotion Model
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after she noticed the trend of primary care providers increasingly treating patients after 
they were diagnosed instead of educating them on preventative practices to improve 
wellness. Instead of focusing on negative motivation practices to treat the patients, 
Pender (2011) developed this model with positive motivation as the focus. Pender stated 
that patients and primary care providers are more likely to participate in a certain 
behavior if they anticipate a valued benefit (Petiprin, 2016). The purpose of the Health 
Promotion Model was to assist nursing professionals in the understanding of the different 
elements of health behaviors. Nursing professionals can then provide the patients with 
accurate information and guidance on promoting healthy lifestyles based on their 
personal health habits. The theory encourages learners to examine the different lifestyle 
choices that ean impact health behavior. Pender’s Health Promotion Model lists three 
major components: individual characteristics and experiences, behavior-specific 
cognitions and affect, and behavioral outcome. The individual characteristics and 
experiences component includes any prior related behavior or personal factors, e.g., 
biological, psychosocial, or sociocultural. The biological factors are inherited traits, e.g., 
physical appearance, age, sex, pubertal status, and strength. The psychosocial factors 
include self-perception, self-esteem, definition of health, and where patients see the status 
of their health. The sociocultural factors include race, education, and insurance status. 
Prior related behavior, psychosocial, self-esteem, and their definition of health can have a 
great impact on sexual behaviors of individuals, especially the adolescent experiencing 
puberty. In the behavior-specific cognitions and affect component, there are multiple 
perceptions and influences including perceived benefits of action, perceived barriers to 
action, perceived self-efficacy, activity-related affect, interpersonal influences, situational 
influences, commitment to a plan of action, and immediate competing demands. The
8
survey could increase college students’ awareness of HPV and benefits of the available 
vaccination for protection. This study focused on the individual characteristics and 
experiences and behavior-specific cognitions and affect components of Pender’s Health 
Promotion Model by assessing the knowledge these college students have in regard to 
HPV, HPV-related illnesses, and actions the students can take to prevent HPV.
The individual characteristics and experiences and behavior-specific cognitions 
and affect components lead to the final component, behavioral outcome, which results in 
health-promoting behavior. When primary care providers educate college students on 
HPV and the effects it can have on their lives, these students can make an informed 
choice as to whether or not they participate in and commit to health-promoting behaviors. 
Compliance to the complete uptake of the vaccination was just one example of health- 
promoting behaviors investigated in the current study. Pender defined health-promoting 
behavior as the desired behavioral endpoint or outcome of health decision-making and 
preparation for action (Pender, 2011).
According to Sakraida (2014), Pender identified health promotion as a goal for 
the 21st century—just as disease prevention was a task of the 20th century. It is 
important for medical professionals involved in patient care to understand the 
determinants affecting health behaviors so that the patient and medical professional can 
work together—allowing the patient to achieve a higher quality of life.
Studying health and social behaviors of college students ages 18-26 years, along 
with supportive and preventative measures, will help increase awareness of this 
preventable disease. Pender (2011) stated that patients and primary care providers are 
more likely to participate in behavior if they see a benefit. For this study, the knowledge 
of HPV, the HPV vaccination series, and vaccination compliance for this disease was
examined with the hopes of raising awareness of HPV and prompting college students to 
seek information that will in turn improve health-promoting behaviors, such as 
vaccination as a preventive measure against HPV.
Research Questions
The following research questions were the focus of the study:
1. Are college students ages 18-26 years knowledgeable of the HPV and HPV- 
related diseases?
2. Are college students ages 18-26 years knowledgeable of the HPV vaccine?
3. Are college students initiating the HPV vaccination series?
Definition of Terms 
College students
Theoretical: College students were defined as scholars enrolled in school 
(Webster, 2017).
Operational: College students were defined as people ages 18-26 years enrolled 
at a university and seeking treatment at the university student health center.
Knowledgeable
Theoretical: Knowledgeable was defined as having or showing knowledge or 
intelligence (Webster, 2017).
Operational: Knowledgeable was defined as college students’ knowledge of HPV 
and the HPV vaccine. Knowledge of HPV was assessed by 24 true and false  questions 
related to HPV disease. A score of 0 was given for each incorrect answer, and a score of 
1 was given for each correct answer with a total of 24 points possible. College students 
with a total score of 17 points or higher were considered knowledgeable of HPV. 
Knowledge of the HPV vaccine was assessed by 6 true and false questions related to the
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HPV vaccine. A score of 0 was given for each incorrect answer, and a score of 1 was 
given for each correct answer with a total of 6 points possible. College students with a 
total score of 5 or higher were considered knowledgeable of the HPV vaccine.
Human papillomavirus
Theoretical: Human papillomavirus (HPV) was defined as any numerous 
papillomaviruses that cause various human papillomas and are associated with the 
production of some human cancers (Webster, 2017).
Operational: Human papillomavirus (HPV) was defined as HPV types 6 and 11, 
which are linked to genital warts, and HPV types 16, 18, 31, 33, 45, 52, and 58, which are 
linked to cervical, vulvar, vaginal, and anal cancers.
Human papillomavirus-related diseases
Theoretical: Human papillomavirus-related diseases were defined as a DNA 
tumor virus that causes epithelial proliferation at cutaneous and mucosal surfaces. More 
than 100 strains exist and are associated with cervical, vulvar, vaginal, and anal cancers 
and genital warts (CDC, 2015a).
Operational: Human papillomavirus-related diseases were defined as diseases 
linked to the HPV that included the following: cervical cancers, anal cancers, ovarian 
cancers, penile cancers, oral/pharyngeal cancers, and genital warts.
Human papillomavirus vaccine
Theoretical: Human papillomavirus vaccine was defined as a vaccine which 
proved to be 100% effective in preventing the most common strains of HPV that leads to 
cancers and other diseases (Venes, 2013).
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Operational: Human papillomavirus vaccine was defined as an immunization that 
protects against the HPV strains that are responsible for most cervical cancers, 
oral/pharyngeal cancers, vaginal cancers, penile cancers, and genital warts.
Human papillomavirus vaccination series
Theoretical: Human papillomavirus vaccination series was defined as an 
immunization series that protects against the most common strains of HPV that lead to 
cancers and other diseases. The series consists of two injections for males and females 
ages 9-14 years and is administered at 0 and 6-12 months. The 3-dose schedule is for 
males and females ages 15-26 years and should be administered at 0, 2 months, and 6 
months (Meites et al., 2016).
Operational: Human papillomavirus vaccination series was defined as the 
vaccination series consisting of three injections due to the age of participants being ages 
18-26 years.
Summary
This chapter established the prevalence of HPV along with its associated cancers 
and diseases. The CDC (2015a) suggested that the most effective way to prevent HPV- 
associated infections and HPV-related cancer is through vaccination. The theoretical 
framework used in this research supports the benefits of health promotion by primary 
care providers in the healthcare setting. This chapter has defined the purpose of the 
study, the problem statement, and the research questions that support the relevance of 




HPV is the most common sexually-transmitted infection in the U.S. and is 
associated with multiple cancers and genital warts. The most effective way to prevent 
HPV-related illness and HPV-related cancers is vaccination; however, varied vaccine 
uptake has been reported since FDA approval and release of the HPV vaccine (Meites et 
al., 2016). The purpose of the current study was to evaluate the knowledge of college 
students ages 18-26 years regarding HPV and the HPV vaccine, as well as vaccine 
compliance among these students. This chapter details the conceptual framework and 
previous studies regarding HPV that identified areas for further research and served as a 
foundation for the current study.
Conceptual Framework
Nola Pender’s Health Promotion Model served as the theoretical basis for this 
research study. As stated by Pender, the purpose of the Health Promotion Model is to 
“assist nurses in understanding the major determinants of health behaviors as a basis for 
behavioral counseling to promote healthy lifestyles” (Pender, 2011, p. 2). The 
determinants of health behaviors evaluated in this study were knowledge of HPV, 
knowledge of the HPV vaccine, and vaccine uptake among college students. Gaining an 
understanding of these factors can assist the nurse in developing interventions that affect 
multiple components of the Health Promotion Model. Increasing awareness of HPV and 
the benefits of the vaccination can lead to the desired health-promoting behavior of 
vaccination.
Martinelli (1999) used Pender’s Health Promotion Model to test an explanatory 
model of variables that can influence health promotion behaviors in smoking and
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nonsmoking college students. Using the Health Promotion Model as a framework, the 
researcher developed a model that uses active and passive smoking as predictive of 
performing health-promotion behaviors (HPB). Pender’s model was chosen because 
components of the model—prior related behavior, personal factors, and self-efficacy— 
have relevance to active and passive smoking. Furthermore, the model had not been 
tested in college students, and few studies have included tobacco use as a construct. The 
researcher hypothesized that the following factors contribute to the performance of 
health-promoting behaviors: (a) prior related behaviors of smoking status and avoidance 
of environmental tobacco smoke (ETS); (b) personal factors of gender, health locus of 
control and perceived health status; and (c) self-efficacy. Pender further hypothesized the 
following:
1. Prior related behaviors and personal factors would have both direct and 
indirect effects on HPB.
2. Self-efficacy would have a direct effect on performance of HPB and serve as a 
mediating variable for prior related behaviors and personal factors.
The researchers used an ETS Avoidance Scale, Multidimensional Health Locus of 
Control Scale, and Self- Efficacy Scale to assess the independent variables. The Health 
Promotion Lifestyle Profile I was used to describe health-promoting behaviors in this 
population and was the dependent variable, or outcome, for this study. Independent 
variables were first assessed for multicollinearity. Then, path analysis, a form of multiple 
regression, was used to test the model. Avoiding ETS, perceived health status, and self- 
efficacy were the three variables that had a significant effect on the performance of 
health-promoting behaviors. Self-efficacy was the strongest predictor of the performance 
of HPB. Avoidance of ETS had both strong direct and indirect influence on performance
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of HPB. Perceived health status had both direct and indirect influence on the 
performance of HPB in this study. External control of health locus had direct influence 
on performing HPB and had no indirect influence which offers encouraging evidence of 
the direct influence of provider teaching and recommendations. Smoking status was 
eliminated, as it had no direct or indirect effect. Surprisingly, nonsmoking was not 
predictive of performance of HPB. The findings of the study support the relationships 
proposed in Pender’s Health Promotion Model between prior related behaviors, personal 
factors, and self-efficacy. Outcomes of this study suggested that successful health 
promotion programs for college students may focus on short-term benefits and 
enhancement of self-efficacy rather than long-term abstract concepts.
Knowledge interventions that affect the behavior specific cognitions and affect 
components of the Health Promotion Model could improve intent and uptake of the HPV 
vaccine. Martinelli’s (1999) health promotion theory-based study of college students 
suggested that focus on short-term benefits and enhaneement of self-efficacy would 
produce the most effective intervention to reduce active and passive smoking—an 
important finding for constructing interventions aimed at college students and one that 
can be applied to other health-promoting behaviors such as vaccination. The 
questionnaire used in the current study yielded data that can be applied to Pender’s 
Health Promotion Model as the information obtained from the above study was applied. 
The information collected in this study provided a foundation on which to build effective 
interventions that increase the health-promoting behavior of HPV vaccine uptake, and the 
Health Promotion Model provided the blueprint for the construction of the interventions.
15
Review of Related Research
Conroy et al. (2009) performed a study involving HPV vaccine participation. The 
study focused on poor minority women who are at greater risk for HPV infection and 
subsequent cervical cancer. The data source for this longitudinal study performed during 
the last 6 months of 2007 was a group of 13- to 26-year-old females from an urban, 
hospital-based clinic. This study had the following three goals:
1. Describe the rate of vaccination in this group during the first 12-18 months 
after the vaccine was introduced.
2. Identify which factors best predicted actual vaccine receipt at follow-up.
3. Identify barriers among those who did not receive the vaccine at follow-up.
In order to participate in the study by Conroy et al. (2009), women must have had
previous sexual contact with a partner and be able to read and write in English or 
Spanish. The women gave their written consent and were asked if they would agree to 
telephone contact at a later date for a follow-up study. The baseline survey included 
questions about demographic factors, gynecological history, risk behaviors, HPV 
vaccination history, and intention and self-confidence to receive the HPV vaccine.
Written information about HPV infections and vaccines were given to the 262 
participants in the baseline study. The follow-up telephone survey evaluated whether or 
not the study participants had received a dose of the HPV vaccination and, if so, the date 
of the vaccination. Confirmation of the dates provided was carried out by checking the 
state immunization registry; problems, if any, were resolved by chart review. Of the 262 
women who completed the original survey, 189 participated in the follow-up. The time 
parameters of the study were the 6 months between the baseline survey and the telephone 
follow-up. The variables considered in this study by Conroy et al. (2009) included age.
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insurance coverage, history of pregnancy, history of abnormal Pap tests, condom use at 
last sexual intercourse, intention to receive the vaccine, and normative beliefs.
At follow-up from the baseline survey, 36% {n = 68) of the participants had 
received at least one dose of the HPV vaccine. The attitudinal and behavior predictors of 
receiving the vaccine were found to be younger age, insurance coverage for the vaccine, 
condom use at last sexual encounter, no history of abnormal Pap test, no pregnancies, and 
normative beliefs. Normative beliefs were defined as the belief that one’s parents, 
partners, and clinicians endorsed HPV vaccination. Intention to receive the vaccine had 
no measurable influence. Participants with insurance coverage were 5 times more likely 
to receive the vaccine. Conroy et al. showed that a one-unit increase on a scale of 
normative beliefs was associated with a doubled increase of vaccine uptake. In the study, 
121 women had received no dose of the vaccine at follow-up. Of these 121 women, 45% 
had failed to return to the clinic since the baseline visit, which was the most common 
self-reported variable. Of the young women who did return to the clinic, 42% had not 
been offered the vaccine and 12% had been offered the vaccine but declined to receive it. 
The most frequently reported reason for refusing to receive the vaccine was insurance 
coverage—reported by 86.7% of those giving a reason for refusal. Conroy et al. (2009) 
suggested that proactive outreach to targeted at-risk college-age women, including 
positive and knowledgeable promotion of the vaccine by clinicians and counseling about 
insurance benefits, would help increase vaccination rates.
This study by Conroy et al. (2009) exhibited the importance of intervention by 
healthcare providers in increasing HPV vaccine participation. As data were collected in 
2007, the study also provided vaccination rates for comparison to the current study over a 
10-year period.
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Licht et al. (2010) performed a cross-sectional study to assess rates of HPV 
vaccination and to examine whether knowledge and risk perceptions regarding HPV are 
associated with the reported use of the HPV vaccine among female college students.
Licht et al. (2010) hypothesized that correlates of receiving the HPV vaccine are present 
and included demographic variables, as well as knowledge items and the perceived risk 
of acquiring and transmitting HPV to others. The researchers also hypothesized that lack 
of awareness of HPV effects, including its association with cervical cancer, is related to 
lower rates of vaccination uptake among adults ages 19-26 years.
The study consisted of 406 college-aged women ages 18-26 years from 2 separate 
public universities. The researchers used a self-administered survey to collect 
information regarding demographics, sexual and health behaviors, HPV vaccination, 
attitudes and perceptions regarding the HPV vaccine, and a series of items on knowledge 
of HPV. Independent variables included demographics, school attended, age, race, 
ethnicity, and religion. The dependent variable was the self-reported completion of the 
HPV vaccine. The researchers used descriptive statistics and tests to explore 
relationships between variables. With the use of the SPSS V.14.0 software, multivariate 
logistic regression models were used to identify correlates of receiving the HPV vaccine.
After analysis, 43.6% of 406 female students reported having received at least one 
dose of the HPV vaccine. Female students, 18-years old, were 4 times more likely to 
report vaccination than those ages 19-26-years. African American and Asian women 
were each less likely to be vaccinated than Caucasian women. Those who correctly 
identified HPV as a cause for genital warts and penile cancer were 1.85 times more likely 
to have received at least one dose of the HPV vaccine. The students sampled 
demonstrated higher levels of knowledge for selected items on HPV disease outcome and
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transmission and the availability of the vaccine and lower levels of knowledge about 
HPV as a cause for genital warts, penile cancer, transmission via skin-to-skin contact and 
that rates of HPV among men and women are comparable. Significant misperception of 
risks associated with HPV was observed, as 22% of students sampled rated their risk of 
acquiring HPV as high, 63% as low, and 15% did not know. Similarly, the overall risk of 
transmitting HPV to others was rated high by 12%, low by 67%, and 21% did not know. 
After adjusting for demographic characteristics and the summary knowledge score, the 
perceived risk of HPV acquisition and transmission was not a predictor of HPV 
vaccination.
This research by Licht et al. (2010) served as a foundation for the current study by 
providing knowledge items to be replicated and vaccination rates for comparison. The 
current study used a similar instrument, a self-administered questionnaire to collect data. 
Evaluating similar knowledge items and comparison of vaccination rates approximately 7 
years later can add to the current research on HPV vaccination in the college population.
O’Rarity (2012) performed a gender comparison study among college-aged men 
and women to assess their knowledge and attitudes regarding HPV and the HPV vaccine. 
The study was conducted by administering a questionnaire to a convenience sample of 
college students at the University of Southern Mississippi. The questionnaire was 
approximately 40 questions in length, and the respondents had to be ages 18-26 years to 
complete the questionnaire. Between 3 classes, a total of 100 questionnaires were 
completed, but only 95 fit the criteria to be used in the research. The desired variables of 
the study were to assess the knowledge and attitudes of college students regarding HPV, 
particularly male college students.
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According to O’Flarity’s (2012) research, the results of the questionnaire were as 
follows: In reporting vaccination status, 22% of the 95 participants {n = 20) had 
completed the three-part series of the HPV vaccine, and 7.4% {n = 7) had partially 
completed it. All 27 of these respondents were females, while no male respondents 
indicated being vaccinated with at least one dose. In reporting awareness of HPV, 67% 
of total respondents had heard of HPV before taking the survey. Knowledge scores of 
HPV could range from a total score of 0 to 17. Females’ overall scores averaged slightly 
higher than males, but no significant difference was evident. In regard to which health 
issues were related to HPV, 40.0% of males versus 79.2% of females answered cervical 
cancer, 37.5% of males versus 24.5% of females answered genital warts, and 15.0% of 
males versus 5.7% of females answered oral cancer. O’Flarity (2012) helped identify 
that there is a knowledge deficit among college students pertaining to HPV, to the HPV 
vaccine, as well as lack of compliance with the vaccine. The study also identified that 
while college students are aware of the most advertised effects of HPV, there is still a 
considerable lack of knowledge about all cancers associated with HPV.
O’Flarity (2012) recognized the need for further research in order to gather more 
insight into attitudes regarding HPV susceptibility and the HPV vaccine. O’Flarity 
recommended a series of follow-up studies in order to track changes in knowledge and 
attitudes over time and ideally HPV vaccination status accordingly. The researcher also 
recommended a study of qualitative nature to help determine why males are choosing to 
be or not to be vaccinated.
The current study addressed O’Flarity’s recommendation for future studies to 
assess college students’ knowledge of the HPV, the HPV vaccine, and compliance to the 
vaccine over a period of time. O’Flarity’s (2012) study also provided individual survey
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items for duplication in the current study and has particular relevance, as it was 
conducted on a college campus in the same state as the current study.
Daley et al. (2010) performed a cross-sectional study for the purpose of 
examining factors associated with HPV vaccination in college-aged females. The 
researchers’ purpose was to identify factors associated with vaccine uptake and to 
determine vaccination rate among the selected population.
The study by Daley et al. (2010) was conducted at a large, public, metropolitan 
university located in the southeastern part of the U.S. The population was comprised of 6 
sections of a required introductory undergraduate social science class. All students in the 
class were offered the opportunity to complete the questionnaire. Male responses, those 
outside of the age range of 18 to 26 years, those who reported not having heard of HPV, 
and those with incomplete vaccination status data were excluded from the study, yielding 
a convenience sample of 256 female students with a mean age of 18.9 years. The data 
instrument was a paper-and-pencil questionnaire that assessed independent variables of 
demographic characteristics, HPV knowledge, HPV vaccination beliefs, information 
sources, and importance of healthcare provider recommendation. The dependent variable 
was self-reported receipt of the HPV vaccine. The questionnaire was completed in class, 
and afterward students were given a resource sheet with information on the HPV vaccine 
and trusted online health information sources.
Statistical analyses were conducted utilizing SAS 9.2 software. Chi-square tests 
were used to compare each individual knowledge question to self-reported receipt of the 
HPV vaccine. Then, logistic regression analyses were performed to assess odds of 
vaccination with each independent variable which included summed HPV knowledge
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score, HPV vaccine beliefs, information sources, and importance of healthcare provider 
recommendation.
The rate of vaccination overall was 43%. Vaccination rates did not differ 
statistically among age, race, or ethnic groups. Of individual knowledge statements, 2 
were statistically significant with relation to vaccination status. There is a vaccination 
fo r  women that prevents certain types o f HPV  and HPV can be cured were both answered 
correctly by statistically significantly more vaccine recipients. Bivariate logistic 
regression yielded evidence that vaccine recipients had higher knowledge scale scores, 
were more likely to report knowing someone who has received the vaccine, to rate 
healthcare provider recommendation as very important, and to believe that the HPV 
vaccine is safe. Vaccine recipients also most often reported family members and 
healthcare providers as sources of information on HPV. Vaccine non-recipients were 
more likely to report radio or television commercials as sources of information. Non­
recipients also reported healthcare provider recommendation as somewhat important 
(versus very important for the vaccinated group).
Daley et al. (2010) noted that increased time since the vaccine was released may 
have played a role in the high rates in this study. Daley et al. also noted that Merck, the 
company that produces the HPV vaccine Gardasil, had heavily invested in a multimedia 
campaign on the campus where the study took place. Flyers promoting Gardasil and 
other HPV studies in the Women’s Health Center on campus may have influenced the 
higher vaccination rates. The study showed that 3 factors (media campaigns, provider 
recommendation, and family) may play a vital role in vaccine uptake among college-aged 
women. Daley et al. concluded that continuing education for providers who treat 
preadolescent to college-age women may be beneficial for increasing vaccination rates.
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The method of scoring of individual knowledge items as well as overall 
knowledge scores was duplicated in the current study. Daley et al. (2010) also provided 
individual knowledge and HPV vaccine belief survey items for comparison with the 
current study findings, adding to the research on HPV in the college-aged population.
Gerend and Shepherd (2011) performed a study analyzing HPV awareness and 
knowledge as related to demographics, health history, sexual history, and socio­
political factors. The purpose of the study was to identify factors associated with HPV 
knowledge in unvaccinated women aged 18 to 26 years since the HPV vaccine has 
become widely available. In 2006, the Food and Drug Administration approved a 
quadrivalent HPV vaccine for use in females ages 9 to 26 years. In 2009, a bivalent HPV 
vaccine was approved for use in the same group. Since release of the vaccines, studies 
revealed uptake of at least one injection in about 44% of females aged 13 to 17 years, but 
only about 10% of young women aged 18 to 26 years reported receiving at least one HPV 
vaccination. Few studies have been performed that identify links of HPV knowledge and 
rate of vaccination, and most of those were performed prior to the release of the vaccine.
Gerend and Shepherd (2011) hypothesized that certain characteristics, such as 
demographics, sociopolitical alignment, sexual history, and health history, would be 
associated with increased awareness and knowledge of HPV. Gerend and Shepherd 
sought to answer 2 questions:
1. In females aged 18 to 26 years, what variables correlate with HPV awareness 
and knowledge?
2. Are unvaccinated females aged 18 to 26 years knowledgeable regarding HPV?
The study by Gerend and Shepherd (2011) was conducted on the campus of
Florida State University. The study participants were recruited via the college’s web-
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based course management system, flyers posted on campus, and the school’s psychology 
department student pool. The 47 participants recruited from the psychology department 
student pool received course credit for participating in the study. Invitations to 
participate in the study were sent via email until the target sample size of 735 was 
reached. A computer-administered questionnaire was used to evaluate awareness and 
knowledge of HPV. Items used on the questionnaire were derived from previous studies. 
Awareness was evaluated with a simple yes!no question of Before you came here fo r  this 
study today, have you ever heard o f HPV? Knowledge was assessed using 10 questions 
that participants could choose answers of True, False, or D on’t Know. The survey also 
included questions pertaining to demographic information, sexual history, health history 
(including previous exposure to HPV and history of cervical dysplasia), and 
sociopolitical affiliation, such as conservative or liberal leaning, and attitudes toward 
premarital sex. The collection of data occurred from March 2009 to August 2009. Data 
were analyzed using several methods. Descriptive statistics were computed for all 
variables. Pearson product-moment correlations were used for continuous variables and 
point biserial correlations were calculated for dichotomous variables and continuous 
variable correlations. Finally, hierarchical multiple regression was used to identify 
variables independently associated with HPV knowledge.
The study determined that HPV awareness is high. Only 3% of study participants 
had never heard of HPV prior to the study. Knowledge of HPV was only moderate 
among those who were familiar with HPV; the mean score for knowledge was 4.9/10.
The study supported Gerend and Shepherd’s (2011) hypothesis that certain 
characteristics would be associated with increased knowledge of HPV. Variables that 
significantly correlated with higher HPV knowledge were the following: (a) increased
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age and more years of education, (b) currently involved in a romantic relationship, (c) 
having ever had sexual intercourse, (d) having higher numbers of lifetime sexual 
partners, and (e) prior HPV testing and provider recommendation. The increase in these 
variables raised concern that the reason for knowledge may be exposure to HPV. 
Variables that correlated with lower knowledge of HPV were Latina/Hispanic ethnicity, 
politically conservative alignment, and born again or evangelical Christian affiliation. 
The study identified significant gaps in the participants’ understanding of the nature and 
consequences of HPV. The unanticipated finding of remarkably low knowledge among 
Latinas/Hispanics, the ethnicity with highest rates of cervical cancer in the U.S., is 
significant and identified an environment for further research and improvement. The 
high percentage of awareness among this unvaccinated population also identified that 
awareness does not necessarily lead to acceptance and uptake of the vaccination, though 
the researchers were hopeful that more knowledge would lead to more vaccine uptake. 
Gerend and Shepherd (2011) recommended future study in the Latina/Hispanic 
population to replicate their findings and explore reasons for the knowledge gap.
Gerend and Shepherd (2011) reported that over 10 years after the release of the 
first HPV vaccine, the population at highest risk continues to be the population with 
lowest vaccine uptake. Clearly, more insight is needed in this age group to tailor 
interventions that increase vaccine acceptance and uptake. This study by Gerend and 
Shepherd (2011) identified multiple areas where more research and improvement are 
needed and directly addressed the research questions of the current study. The current 
research study duplicated knowledge items of this study, providing rich grounds for 
comparison of outcomes. Using similar questions added to the research regarding the 
knowledge of HPV and HPV vaccination in college students.
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Patel et al. (2012) performed a study of female college students to examine HPV 
vaccination intent and to determine whether an educational intervention increased 
vaccine uptake among this population. This study posed 2 questions to be answered by 
the research:
1. What are the potential barriers to HPV vaccination in female college students?
2. In female college students, what is the effect of an educational intervention in 
comparison to standard care on uptake of the HPV vaccine?
These questions were answered by conducting a randomized study of 256 female 
students from the University of Michigan’s University Health System Gynecology Clinic. 
The study population consisted of women aged 18 to 26 years who were full- or part- 
time students at the university that were presenting for routine physical examination and 
who had not received the first dose of the HPV vaccination series.
The 256 students who agreed to participate in the study were equally divided into 
an educational intervention group and a standard care group. Group assignment was 
determined randomly by number assignment prior to study recruitment with the help of a 
computer program. All participants completed a questionnaire that contained 
sociodemographic information, items regarding HPV knowledge, and items regarding 
HPV personal beliefs. The standard care group received a standard HPV vaccination 
information sheet and brief mention of HPV vaccine during their visit, which is 
customary for all patients during their routine examination. The educational intervention 
group received a more detailed HPV and vaccination fact sheet and a detailed discussion 
of the fact sheet by the study coordinator. A reminder letter and an additional copy of the 
fact sheet were mailed 2 weeks later. Medical record review and participant contact by
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mail, telephone, and email were used to assess vaccine uptake 6 months after study 
enrollment. Patel et al. (2012) used a self-administered survey to assess independent 
variables of knowledge of the HPV vaccine, personal beliefs about HPV and vaccination, 
as well as a sexual and health history. The dependent variables for the study by Patel et 
al. (2012) included intent to vaccinate at the time of survey completion and vaccine 
uptake within 6 months after the study. The voluntary survey was completed prior to 
being seen by the provider in the clinic.
SAS software was used for statistical evaluation. Bivariate logistic regression 
was used to associate demographics, sexual history, and health history. Multivariate 
logistic regression models were used to associate personal beliefs and HPV knowledge 
with intent to vaccinate, supplemental health insurance coverage, and current sexual 
activity. Bivariate association was used to determine the impact of the knowledge 
intervention.
According to Patel et al. (2012), the most significant factor influencing vaccine 
uptake was intent to vaccinate. Study participants who intended to undergo vaccination 
at the time of survey completion were over 10 times more likely to receive at least one 
dose of HPV vaccine within 6 months of enrollment. The research concluded that 41.0% 
of the participants intended to vaccinate, 31.3% did not intend to vaccinate, and 26.2% 
were undecided. Vaccine uptake was low. Only 5.5% of participants reported receiving 
the HPV vaccine, and vaccine uptake did not differ by study group. Personal belief 
factors influencing intent to vaccinate in this study by Patel et al. (2012) included 
provider recommendation and worry about cervical cancer, HPV, and genital warts. The 
belief that they are likely to acquire HPV in their lifetime and that parents would approve 
of them getting the HPV vaccine were associated with increased intent. Having
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supplemental insurance coverage and current sexual activity were also statistically 
associated with intent to vaccinate. Factors identified by those intending not to vaccinate 
included the following: (a) concern about vaccine safety and side effects, (b) high out-of- 
pocket costs, (c) long-term consequences, and (d) perception of not being at risk for STIs 
or genital warts. HPV-related knowledge was also found to be high with a mean 
knowledge score of 4.46/6 and was not significantly associated with intent to vaccinate. 
The educational intervention was not associated with higher uptake of the vaccine in this 
study. The major implication of this research was the identification of personal beliefs as 
a major influence in intent and ultimately uptake of the HPV vaccine. Patel et al. (2012) 
also indicated that identifying the barriers to vaccination follow through could help close 
gaps between intent to vaccinate and actual uptake and that further study is needed to 
evaluate risk perception and preventive behaviors in college students. Patel et al. (2012) 
benefited the current research project by providing risk perception and knowledge items 
of the survey. Patel et al. (2012) reported a vaccination rate of 5.5%—very low 
compared to Licht et al.’s (2010) reported rate of 43%. The study by Patel et al. (2012) 
also highlighted gaps in the research for further exploration, such as risk perception or 
personal beliefs regarding HPV vaccine.
Patel et al. (2013) conducted a study using the Transtheoretical Model of Change 
(TTM). The study examined the differences in HPV vaccine stages of change related to 
gender differences following the recommendations for permissive use of the HPV 
vaccine in males. The researchers wanted to ascertain whether and to what degree 
gender, beliefs, and attitudes attributed to the students’ progression through the stages of 
change influenced the inclination to undergo HPV vaccination.
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Data collected from the self-administered online survey included 
sociodemographic characteristics (i.e., age, current student standing, current enrollment 
status, race, marital status, supplemental health insurance coverage, sexual history, age at 
first sexual intercourse, lifetime number of sex partners and gender of sex partners among 
those who have had sexual intercourse); knowledge and sources of information about 
HPV, personal beliefs about HPV infection, HPV-associated disease, and HPV 
vaccination; intention to undergo HPV vaccination and factors influencing this decision; 
perspectives regarding healthcare; charitable/altruistic practices; and sexual and health 
history. The use of the TTM model allowed for a distinct method to interpret the 
progressive process of change. The pre-contemplation stage, the contemplation stage, the 
preparation stage, the action stage, and maintenance stage were assessed by the 
participants’ responses to statements, such as “I do not plan to get vaccinated ever,” “I 
am unsure about my intention to get vaccinated,” and “I have made or tried to make an 
appointment to get vaccinated against HPV.”
The researchers recruited participants using a convenience sample. All part-time 
and full-time enrolled students aged 18-26 years were invited to participate in the study 
via electronic mail (e-mail) sent out by the Office of the Registrar. The communication 
included a secure anonymous link through SurveyMonkey.com to complete the survey.
A total of 29,388 individuals met the inclusion/exclusion criteria and were sent the e-mail 
invitation to participate in the study, of which 2,958 responded. A second e-mail was 
sent to all participants approximately one week later, and an additional 1,169 individuals 
responded. After exclusion of 108 individuals whose inclusion/exclusion criteria could 
not be verified, the final sample consisted of 4,019 respondents.
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Basic descriptive statistics were used to describe the sociodemographic 
characteristics, sexual history, HPV vaccination stages of change, and HPV-related 
beliefs and attitudes of the study sample overall and by gender. Chi-square tests were 
used to compare characteristics between females and males. Of the 4,019 respondents, 
3,080 (76.6%) were female and 939 (23.4%) were male. Overall 3,234 (80.5%) 
participants were in at least the contemplation stage. Males were found to be in the 
earlier stages of change compared with females {p < .0001). Only 70.2% of males were 
in the contemplation stage compared to 83.6% of females. Most respondents had a 
positive and desirable attitude and agreed with the attitudes and beliefs that were 
assessed, but < 20% agreed with the following statements: “I am likely to get a genital 
HPV infection in my life time,” “I am likely to develop HPV-related cancer in my 
lifetime,” and “I am likely to develop genital warts in my lifetime.” Although many of 
the participants’ responses to the HPV related beliefs and attitudes portion of the survey 
indicated they were in at least the contemplation stage of vaccination, participants of both 
genders agreed on the following statements that were not indicative of being in at least 
the stage of contemplation: “Having genital HPV would make it difficult for me to get a 
long-term partner,” “I am likely to develop HPV-related cancer in my lifetime,” and “I 
am likely to develop genital warts in my lifetime.”
Patel et al. (2013) found that college students agreed with the benefits of the HPV 
vaccination for individuals and society as a whole. The students’ beliefs of the benefits 
of the HPV-vaccination are substantially related to having contemplated receiving the 
HPV vaccination. Although a majority of the participants had positive beliefs about the 
benefits of the HPV vaccination, < 20% perceived that they were at risk for contracting a 
HPV infection. The results show that males had at least contemplated undergoing
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vaccination, but females had advanced further toward taking observable steps in 
receiving the vaccine.
Patel et al. (2013) identified college students as an important catch-up population 
for undergoing the HPV vaccination. Previous studies have centered on acceptability and 
uptake. In this study, researchers focused on the gender differences in college students’ 
readiness to undergo the vaccine (healthier behavior) and aspects associated with 
contemplation of the vaccine. The focus on gender differences related to HPV in this 
study by Patel et al. (2013) prompted interest in gender differences in the current study 
and provided information for comparison. Significant differences in knowledge and 
vaccine uptake between genders may identify an area of focus for further research and for 
educational interventions.
Navalpakam et al. (2016) performed a cross-sectional study to investigate 
attitudes toward HPV infection and vaccination, as well as the readiness for the uptake of 
the HPV vaccine amongst female college students. A cross-sectional survey was 
performed that targeted a randomized sample of 1,000 Oakland University female 
students 18 years old and above. The survey instrument utilized was an online self­
administered questionnaire presented by Google forms.
Independent variables in the study included demographics and information, such 
as the patient’s age, smoking and drinking status, sexual experience, college major, and 
current HPV vaccination status. These variables were included in the first of 4 sections 
of the questionnaire. The second section of the questionnaire asked 16 true or false 
questions to indicate the studied population’s knowledge regarding HPV infection and 
vaccination. The third section offered 9 questions with a 5-point Likert scale on the 
participants’ attitudes toward the HPV vaccination. The fourth section was for the
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participants who had received educational information about the vaccination and 
completion of the third section of the survey. Google forms automatically populated and 
saved digital responses to a secure database to protect the students’ confidentiality.
Of the 1,000 individuals that were approached, 192 students completed the 
survey. Approximately 46% of the participating students were already vaccinated with 
the HPV vaccination; the remaining 54% were not vaccinated. The results revealed that 
95.8% of the participants had previously heard about the vaccine, and 3.6% of the 
students had never even heard of the vaccine. The majority of participants (78.1%) 
reported previous sexual experiences, while 22.1% had no previous sexual activity. A 
majority (92.7%) of the students were nonsmokers, and 54.2% did not drink alcohol. 
Twenty-six percent of the students were pursuing a career in the healthcare field. The 
results from the study revealed that the primary sources of information for the students 
regarding HPV and the HPV vaccine were primary physicians, followed by the media, 
then family and friends.
The participants’ knowledge of HPV vaccine and infection was calculated and 
showed that, on average, each participant answered half of the knowledge questions 
correctly. Individuals who were seeking a degree in healthcare-related studies were 
shown to have a significantly higher level of knowledge than those in nonhealth-related 
majors. Consequently, the other analyzed variables, such as smoking status, alcohol 
consumption, vaccination status, and whether the participant had heard of the HPV 
vaccine, did not have a significant influence on the participants’ knowledge regarding the 
HPV vaccine and infection.
After the survey was completed and the educational information had been 
distributed, Navalpakam et al. (2016) analyzed the number of participants who intended
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to receive the HPV vaccination on a scale of 1 to 10, with 1 being the least likely and 10 
being the most likely to receive the vaccination. The mean intention score of receiving 
the vaccination after completion of the survey was 6.51, with a standard deviation of 3.51 
and a median of 7.0. Pearson correlations relating to the knowledge and attitudes were 
calculated showing that participants with higher knowledge about HPV considered 
recommending the vaccination to other female college students, with a correlation factor 
of 0.20 (p = .005). Participants with a higher knowledge score about HPV believed that 
gynecologists should recommend the vaccine to female patients coupled with their belief 
that HPV is a vaccination that they would recommend to their friends. Furthermore, 
Navalpakam et al. (2016) revealed that the group of students having a higher HPV 
knowledge score believed that the side effects of the vaccination series are reasonable 
and, therefore, more willing to receive the vaccine.
Multivariable analysis was conducted to assess correlations between knowledge 
of HPV and the attitude toward HPV. The knowledge awareness of HPV had a beta 
coefficient of 41.9. Navalpakam et al. (2016) revealed that greater awareness of the HPV 
correlates with greater knowledge. This analysis affirmed the need for increasing 
awareness of HPV to increase vaccination rates among college students. Similarly, a 
more positive attitude toward the vaccination showed correlation with a higher 
vaccination rate and increased tendency to recommend the HPV vaccine to peers. This 
implies that increasing awareness leads to increased recommendation and increased 
vaccination. Though HPV infections are the most common sexually-transmitted 
infections, Navalpakam et al. (2016) revealed that the participants’ knowledge of HPV 
was only moderate (53%). Furthermore, 73% of the female students believed that only
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females could acquire HPV. Students with health-related backgrounds were significantly 
more knowledgeable and more likely to have already been vaccinated.
Navalpakam et al. (2016) directly addressed research questions that reflected the 
participants’ attitude toward the HPV vaccination. Data results also provided individual 
vaccination knowledge items and provided a vaccination uptake rate for comparison to 
the current study. While Navalpakam et al. (2016) discovered a relatively high 
vaccination rate and moderate knowledge of HPV, significant knowledge gaps were 
identified among these college-aged women. The current study sought to determine if 
some of the same knowledge gaps existed among male and female college students in 
another geographical region of the U.S.
Crosby et al. (2012) performed a cross-sectional study to determine the 
associations of college men who engage in oral sex and their understanding of the risk of 
oral cancer due to the HPV. There were two main purposes for this study. The 
researchers first sought to identify associations between college males that were engaging 
in various oral sex behaviors and their understanding of the risk of oral cancer. Secondly, 
they sought to identify associations, along with moderating factors, between various 
forms of oral sex and HPV vaccine acceptance.
Crosby et al. (2012) explained that, from a behavioral perspective, it is important 
to investigate whether people engaging in oral sex perceive the behavior as risky for the 
acquisition of HPV. More importantly, the question of whether this perception of risk is 
associated with greater likelihood of accepting the newly approved HPV vaccine 
represented a critical investigation point in the vaccine’s promotion.
Flyers and posters were placed in different areas of 2 university campuses in a 
city located in the southern U.S. area, and the students were to contact project staff if they
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were interested. One hundred fifty males, ages 18-24 years, were recruited to participate 
in an audio-assisted computerized, self-administered interview that lasted approximately 
30 minutes. Participants were compensated $30 for participation. The interview started 
by assessing the perceived risk of oral cancer by asking, “If I did not receive the HPV 
vaccine, I feel that I would be at risk for developing oral cancer?” The response answer 
was chosen from a 6-point scale ranging from strongly disagree to strongly agree. The 
students’ oral sex behavior was assessed among 4 measures: Whether men had “given or 
received” oral sex, the number of partners men had received fellatio from, and the 
number of female partners men had given cunnihngus. Next, the students were asked, 
“Since the HPV vaccine is now available for use in men, how likely would you be to get 
the HPV vaccine within the next year?” to assess the acceptance of the HPV vaccine. 
Lastly, there were 4 factors assessed to determine their influence in regard to behaviors 
and vaccine acceptance. These included race, frequency of communication with parents 
about sex, HPV-related stigma and shame, and the students’ self-efficacy to receive the 
HPV vaccine.
Data were gathered and after analysis it was determined the average age of the 
students in the sample was 20 years and the majority identified as African American or 
Black at 53.3%, 19.3% identified as Caucasian, 21.3% identified as Asian or Pacific 
Islanders, and the remainder identified as “mixed” or members of “other races.” The 
association between perceived risk of oral cancer and selected measures of oral sex 
among college men revealed that men perceived greater risk of acquiring HPV with all 
oral sex behaviors. Regarding the associations between oral sex behaviors and vaccine 
acceptance, men engaging in greater frequency of the oral sex behaviors were more likely 
to indicate they would likely be vaccinated within the next 12 months. The association of
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oral sex behaviors and vaccine acceptance had multiple moderating factors, including 
race. For young men not identifying as African American/Black, recent oral sex was 
associated with greater vaccine acceptance (46.4%). In African American/Black young 
men, greater vaccine acceptance was associated with having more than 2 oral sex partners 
(73.8%), and indicating greater levels of stigma and shame related to HPV (65.5%).
Males (66.7%) that had a greater frequency of communication with parents and oral sex 
engagement in the last 3 months indicated a likely acceptance of the vaccine. Those with 
greater frequency of parental communication and more than 2 oral sexual partners 
representing 71.1 % of the sample indicated likely acceptance of the vaccine. This factor 
was present for both African American and non-African American men. In conclusion, 
the results suggested that college men ages 18-26 years may indeed understand that oral 
sex can increase their risk of oral cancer. Crosby et al. (2012) also suggested that men 
recently engaging in oral sex and those reporting more than 2 oral sex partners are most 
likely more accepting of receiving the vaccine. The intent to get vaccinated was 
verbalized by the young men, but in future studies it would help to offer vaccinations to 
men intending on receiving the vaccine.
This study by Crosby et al. (2012) offered information on risk perception in 
college-aged men for comparison to findings of the current study. Building on 
information obtained by Crosby et al. (2012), findings from the current study will direct 
healthcare providers at the student health center to assess further the patients’ health 
behaviors. In turn, the providers can provide more thorough education to patients on the 
importance of vaccine acceptance.
In summary, a review of the literature revealed vaccination rates ranging widely 
from 5.5% to 46%. Factors identified that may influence vaccination rates included
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overall knowledge of HPV, intent to vaccinate, insurance coverage for vaccination, 
perceived risk of acquiring HPV, age, race or ethnicity, parental acceptance and 
influence, and healthcare provider recommendation. Review of the literature revealed 
that awareness of the HPV vaccine among college-age men and women is high.
However, while knowledge of HPV and its sequelae range from moderate to high, 
significant gaps persist among college students. Young women who identify as 
Latina/Hispanic, politically conservative, or of evangelical Christian affiliation 
demonstrated lower knowledge scores; young men demonstrated lower knowledge scores 
than young women. Study findings are mixed regarding the influence of knowledge and 
intent on vaccination. Multiple aspects of HPV and HPV vaccination have been studied 





The human papillomavirus (HPV) is the most prevalent sexually-transmitted 
disease in the U.S. HPV is responsible for almost all cervical cancers and 90% of all 
genital warts. It is also the cause of a large number of oral/pharyngeal cancers, vaginal 
cancers, and penile cancers. The HPV vaccination series is 100% effective in preventing 
HPV strains 16 and 18 in women and men, which causes about 70% of cervical cancers 
and is 90% effective in preventing genital warts. Despite immunization 
recommendations by the Advisory Committee on Immunization Practices (ACIP), the 
college-aged population has demonstrated low compliance of receiving the vaccination 
series (Daley et al., 2010). The purpose of this study was to determine how 
knowledgeable college students ages 18-26 years are of HPV and the HPV vaccine and 
vaccination compliance among these students. This chapter includes a brief description 
of the design, setting, population, sample, methods of data collection, and data analysis 
that were used in this study.
Design and Setting
After Institutional Review Board (IRB) approval was obtained (see Appendix A), 
the researchers performed a nonexperimental, quantitative research study using a self­
administered pencil-and-paper survey to answer the following research questions;
1. Are college students ages 18-26 years knowledgeable of HPV and HPV- 
related diseases?
2. Are college students ages 18-26 years knowledgeable of the HPV vaccination 
series?
3. Are college students initiating the HPV vaccination series?
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The study took place on a university campus in the southeastern U.S. The 
university has approximately 2,600 students with 81% female and 19% male. Family 
nurse practitioners practice at the student health center and are able to order tests, write 
prescriptions, treat acute illnesses, and refer students to specialists as needed. The health 
center has a registered nurse/office manager and a clinic receptionist on staff. This 
research design and setting were devised as a convenient method to collect data in a short 
timeframe.
Population and Sample
The research study utilized a convenience sample of 30 college students ages 18- 
26 years that signed in as a patient at the student health center on campus. In order to be 
considered for the data analysis, respondents had to be college students who were ages 
18-26 years and were currently enrolled at the university.
Data Collection
The researchers in the current study met with the receptionist, nurse/office 
manager, and primary care providers at the student health center on campus and 
presented the research study. An information packet containing a copy of the 
participant’s informative letter (see Appendix B), the survey (see Appendix C), and a 
letter of consent for the student health center (see Appendix D) was provided to those in 
attendance. The researchers discussed HPV, HPV-related diseases, the HPV vaccine, and 
the purpose of the research study. Researchers also discussed the required criteria for 
participants’ eligibility to complete the survey. Researchers answered the questions 
posed by the health center staff regarding the procedure and purpose of the study. The 
clinic receptionist at the student health center distributed the survey packets to eligible 
participants who had signed in at the student health center. After the staff signed the
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consent letter giving permission to the researchers to use the office as a distribution site, 
100 packets containing the informative letter, the survey, and one pencil were provided to 
the student health center receptionist. When patients signed in at the student health 
center, the receptionist determined if they were eligible to participate in the study 
according to the research criteria. Subsequently, eligible patients were provided a survey 
packet. The informative letter in the packet explained the purpose of the research study 
to participants and included instructions for survey completion. The participants were 
instructed not to put any identifiable patient data on the survey, e.g., name, social security 
number, or birthdate in order to provide anonymity. Once participants completed the 
survey, they placed the survey in the provided envelope, sealed the envelope, and 
returned it to the receptionist. The surveys were left in the student health center for 4 
weeks for data collection and then they were retrieved by the researchers.
The survey included 10 questions that captured the following demographic 
information: age, gender, current year in college, ethnicity, health insurance status, sexual 
history, and immunization status. The study assessed vaccination compliance among the 
participants by two survey questions.
Knowledge of HPV was assessed by 24 true and false  survey questions related to 
HPV disease. A score of 0 was given for each incorrect answer, and a score of 1 was 
given for each correct answer with a total of 24 points possible. College students with a 
total score of 17 points or higher were considered knowledgeable of HPV.
Knowledge of the HPV vaccine was assessed by six true and false  survey 
questions related to the HPV vaccine. A score of 0 was given for each incorrect answer, 
and a score of 1 was given for each correct answer with a total of 6 points possible.
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College students with a total score of 5 or higher were considered knowledgeable of the 
HPV vaccine.
The surveys were kept in the sealed envelopes in a secure location until they were 
opened and viewed by the researchers for data analysis. All data obtained were securely 
stored by using password-protected computers and/or jump drives. All collected data 
were destroyed after compilation and analysis of the results of the research study.
Data Analysis
The researchers reviewed and recorded data gathered from each of the completed 
surveys. The information was sent to a statistician for data analysis. Data were first 
compiled in Microsoft Excel. Subsequent analyses were performed using IBM SPSS 
statistical software, version 22. Inferential statistics were tested using a = 0.05. 
Descriptive and correlation statistics were used to sununarize the data collected. 
Summary
The purpose of this research study was to determine how knowledgeable college 
students ages 18-26 years were of HPV and the HPV vaccine as well as vaccination 
compliance among these students. The data collection tool was a self-administered 
pencil-and-paper survey administered to college students. The statistical tests used to 
analyze the data were methods commonly used by nursing researchers. Prior research 
revealed a knowledge deficit among college-aged individuals and the need for further 




Every year in the U.S., 31,000 women and men are diagnosed with a cancer 
caused by the HPV infection. Most of these cancers could be prevented by the HPV 
vaccination. All sexually active individuals are at risk for contracting the HPV virus; 
therefore, the GDC guidelines recommend that males and females receive vaccination 
against this infection (Meites et al., 2016). The current researchers performed this 
nonexperimental, quantitative research study using a self-administered pencil-and-paper 
survey to determine how knowledgeable college students ages 18-26 years of age are of 
the HPV and the HPV vaccine and vaccination compliance among the studied population. 
Data were compiled in Microsoft Excel. Subsequent analyses were performed using IBM 
SPSS statistical software. This chapter describes the profile of the participant 
characteristics, statistical results, and additional findings.
Participant Characteristics
Data were collected from 30 college students ages 18-26 years. The students 
attended a university in the southeastern U.S. Males and females were chosen to be a 
part of the research study because the CDC recommends vaccination against HPV for 
both genders (Meites et al., 2016). Of the studied participants, the majority were ages 18- 
22 years (76.7%), and the majority were female (86.7%). All student classifications were 
represented in the sample. The most common ethnicity in the sample was Caucasian 
(63.3%). The most common health insurance status was private/commercial (66.7%).
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Findings
1. Are college students ages 18-26 years knowledgeable of the human 
papillomavirus and human papillomavirus related diseases? The answers to 24 true!false 
questions about HPV and HPV- related diseases were scored. Participants received 1 
point for each correct answer, and 0 points for each incorrect answer. Therefore, scores 
had a feasible range from 0 to 24 points. The lowest score received on the questions 
concerning knowledge of the HPV and HPV-related diseases was 10, with the highest 
score being 21. The average score was 17.00 {SD = 2.60).
Scores were further evaluated to determine a pass and fa il rate. A passing grade 
was considered to be 70% correct answers—corresponding to a point value of 17 or 
higher. A score of 16 or lower was viewed as a failing grade. In total, 18 participants 
received a passing grade on the HPV questions (60% passing rate), and 12 participants 
received a failing grade (40% failure rate). A pie chart of HPV knowledge scores is 





Figure 1. HPV knowledge scores.
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2. Are college students ages 18-26 years knowledgeable of the human 
papillomavirus vaccination series? The answers to 6 true/false questions about HPV 
vaccination series were scored. Participants received 1 point for each correct answer, and 
0 points for each incorrect answer. Therefore, scores had a feasible range from 0 to 6 
points. The lowest score received on the vaccination questions was 1, with the highest 
score being 6. The average score was 4.53 {SD = 1.25).
Scores were further evaluated to determine a pass mvdfail rate. A passing grade 
was considered to be 70% correct answers, corresponding to a point value of 5 or higher. 
A score of 4 or lower would be viewed as a failing grade. In total, 20 participants 
received a passing grade on the vaccination questions (66.7% passing rate), and 10 
participants received a failing grade (33.3% failure rate). A pie chart of HPV vaccine 
knowledge scores is shown in Figure 2.




Figure 2. HPV vaccine knowledge scores.
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3. Are college students initiating the human papillomavirus vaccination series?
Of the 30 participants who completed surveys, 43.3% {n= 13) indicated that they had 
taken the HPV vaccination. Of those 13 participants, 23.1% {n = 3) had taken 1 shot, 
38.5% {n = 5) had taken 2 shots, and 38.5% {n = 5) had taken 3 shots. Of the 30 
participants who completed surveys, 50.0% (ji= 15) indicated that they had not taken the 
HPV vaccination, and 6.7% {n = 2) did not answer the question. A pie chart of HPV 
vaccination compliance and vaccination history is shown in Figures 3 and 4.
Vaccination Compliance
50%
■ Not Vaccinated 
H Vaccinated
■ No Answer
Figure 3. Vaccination compliance.
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Vaccination History of the 13 Vaccinated 
Participants
23.1%
38.5% t  One Shot 
Two Shots 
Three Shots
Figure 4. Vaccination history of 13 vaccinated participants.
Additional Findings
The correlation matrix revealed significant correlations between demographics, 
sexual history, vaccination compliance, and knowledge variables. Spearman’s rho 
correlation was used to account for ordinal and binary variables in the dataset.
Descriptive statistics for the variable combinations are shown in Table 1. See Table 2 for 
significant correlations. Correlations between pass rates are not listed in the table, as 
they are redundant with the significant correlations listed for scores.
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Table 1
HPV Knowledge Level, Vaccination Knowledge Levels, and Vaccination Compliance 





Factor Level M SD M SD
Compliance 
rate (%)
Age (years) 18-22 17.39 2.11 4.83 0.98 40.9
23-26 15.71 3.73 3.57 1.62 66.7
Gender Male 16.75 1.71 5.00 .82 66.7
Female 17.04 2.74 4.46 1.30 44.0
Classification Freshman 15.25 1.17 4.50 1.20 50.0
Sophomore 18.00 1.16 4.71 0.95 16.7
Junior 16.90 3.54 4.10 1.55 50.0
Senior 18.67 2.08 533 0.58 100.0
Graduate 18.50 3.54 4.50 2.12 50.0
Ethnicity Caucasian 17.58 2.65 4.84 1.30 38^
African



































Ever Yes 17.30 232 4.50 1.12 57.1
sexually
active No 16.00 3.37 4.57 1.72 14.3
Currently Yes 17.26 2.47 4.63 1.17 52.9
sexually
active No 16.55 238 4.36 1.43 36.4















Variable 1 Variable 2
Correlation
coefficient Significance
HPV score Class 0.463 0.010
HPV score Vaccination 
status 2 0.600 0.030
Vaccination score Ethnicity -0.487 0.006
Vaccination score HPV score 0.505 0.004
The college-aged students that were most eompliant with the vaccination series 
were those ages 23-26 years. Males were more compliant than females in receiving the 
vaccination series. The senior level students were 100% compliant, while sophomores 
were only 16.7% compliant. African Americans proved to be almost twice as compliant 
as Caucasian students. Individuals covered by state-funded health insurance have a 
higher rate of compliance with the vaccine series. Statistics also showed that those who 
were sexually active were more likely to have received the HPV vaccination series.
The correlations show that higher levels of classification correlated with higher 
scores on the HPV questionnaire. Namely, students with higher classifications (e.g., 
junior, senior, graduate) had higher scores than those with lower student classifications. 
Participants with higher levels of Vaccination Status 2 also had higher scores on the HPV 
questionnaire, and participants who had received more shots in the vaccination series 
scored higher on the HPV questionnaire.
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The effect of demographic and sexual history variables on pass rates was 
examined using chi-square tests and cross-tabulations. Two significant chi-square results 
were found. The first, comparing HPV pass rates to classification, showed that higher 
classifications were significantly more likely to have a passing score, X^(4, N=  30) =
11.949, p  = .018. The second, comparing vaccination pass rates to ethnicity, showed that 
Caucasian participants were significantly more likely to have a passing score, X \2 , N  = 
30) = 7.832, p  = .020.
Significant differences in vaccination rates based on demographics and sexual 
history were also explored using chi-square tests and cross-tabulations. Respondents who 
had previously been sexually active had a significant higher vaccination rate than those 
who had not been sexually active, X^(l, N  = 28) = 3.877, p  = .049. No other statistically 
significant differences in vaccination rates were found.
Summary of Findings
Chapter IV reviewed the findings of data collected from 30 college students, 
males and females ages 18-26 years, who attended a university in the southeastern U.S.
In total, the majority were ages 18-22 years and female. The most common health 
insurance among the studied population was commercial insurance. The majority of 
participants reported being sexually active. Data revealed that 60% of the participants 
were knowledgeable of the HPV and HPV-related disease. Additionally, 66.7% of the 
participants were considered to be knowledgeable of the HPV series even though half of 




The human papillomavirus (HPV) is the most prevalent sexually-transmitted 
disease in the U.S. and is responsible for almost all cervical cancers, many 
oral/pharyngeal cancers, vaginal cancers, penile cancers, and 90% of genital warts. The 
Advisory Committee on Immunization Practices (Meites et al., 2016) recommends 
routine HPV vaccination of males and females 11-12 years of age. Since many eollege 
students are sexually active (75-90%) and report an average of > 2 partners per year, they 
are at a unique risk for HPV infeetion (Daley et al., 2010). While the HPV vaecines are 
almost 100% effective in preventing two of the cancer-causing strains and 90% effective 
in preventing genital warts, low compliance of receiving the vaceination series has been 
demonstrated among the college-aged population (Gerend & Shepherd, 2011).
The purpose of this study was to determine how knowledgeable eollege students, 
ages 18-26 years, are of the HPV, the HPV vaccine, and vaccination compliance among 
these students. The conceptual framework for the research project was Pender’s Health 
Promotion Model. As stated by Pender (2011), the purpose of the Health Promotion 
Model is to “assist nurses in understanding the major determinants of health behaviors as 
a basis for behavioral counseling to promote healthy lifestyles” (p. 2). Pender also stated 
that patients and primary care providers are more likely to participate in a certain 
behavior if they anticipate a valued benefit (Petiprin, 2016). For this study, the 
knowledge of the HPV and the HPV vaccination series and the vaccination compliance 
for this disease were examined with the hopes of raising awareness of HPV and 
prompting college students to seek information that will in turn improve health- 
promoting behaviors, such as vaccination as a preventative measure against HPV.
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A convenience sample of 30 college students, ages 18-26 years who signed in at a 
university student health center, completed a 30-question self-administered pencil-and- 
paper survey to answer the following research questions:
1. Are college students ages 18-26 years knowledgeable of the HPV and HPV- 
related diseases?
2. Are college students ages 18-26 years knowledgeable of the HPV vaccination 
series?
3. Are college students initiating the HPV vaccination series?
The study was a nonexperimental, quantitative study. Descriptive and correlation 
statistics were used to summarize data collected.
This chapter is a summary of the findings of the study and will provide a 
discussion of the research findings and how they relate to the current literature. The 
relationship between the research questions and data analysis will be examined with 
notation to possible limitations and potential generalizability of the results. 
Reeommendations based on the findings will be included. Finally, suggestions for future 
research will be provided.
Summary of the Findings
Of the students surveyed, the majority were ages 18-22 years (76.7%), and the 
majority were female (86.7%). The most common ethnicity among the students sampled 
was Caucasian (63.3%), and the most common health insurance status was 
private/commercial (66.7%).
To answer the first research question, the researchers evaluated if college students 
ages 18-26 years were knowledgeable of the HPV and the HPV-related diseases. From 
data colleeted, 18 participants received a passing grade of 70% or higher on the HPV
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question, and 12 participants received a failing grade of < 70%. This concludes that 60% 
of the students sampled were knowledgeable of the HPV and HPV-related diseases.
In Question 2, the researchers were interested in knowing how knowledgeable 
college students ages 18-26 years are of the HPV vaccination series. The lowest score 
possible was 0, and the highest possible was 6. The lowest scored among the students 
sampled was 1, and the highest was 6. When analyzing the pass/fail rate, a score of 5 or 
more would be passing, and 4 or lower would be failing. Of the results, 20 participants 
received a passing grade on the vaccination questions (66.7% passing rate), and 10 
partieipants received a failing grade (33.3%).
The third question was to evaluate college students initiating the HPV series. Of 
the 30 students sampled, 43.3% (n = 13) indicated that they had taken the HPV 
vaccination. Of these 13 participants, 23.1% (n = 3) had taken one shot, 38.5% (n = 5) 
had taken 2 shots, and 38.5% (n = 5) had taken 3 shots. Of the 30 participants who 
completed the surveys, 50.0% (n = 15) indicated that they had not taken the HPV 
vaccination, and 6.7% (n = 2) did not answer.
Discussion of the Findings
The researchers found that the college students ages 18-26 years were moderately 
knowledgeable of the HPV and HPV-related diseases as evidenced by a pass rate of 60% 
among the 30 participants. The expansion of research over the recent years may be the 
reason people are somewhat more knowledgeable about HPV and HPV-related diseases 
than in previous studies. The increased time since a vaccine was approved and available 
to the public may be a factor benefiting the knowledge of college students. Since then, 
advertisements by the producers of these vaccines promoting HPV vaccination have 
increased and may contribute to the increased knowledge as well. These advertisements
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seek to inform the patients of HPV and HPV-related diseases in order to promote their 
vaccine. The findings of the current research were conflicting to those of O’Flarity 
(2012) in that O’Flarity helped identify a knowledge deficit among college students 
pertaining to HPV, HPV vaccine, and a lack of compliance with the vaceine.
Navalpakam et al. (2016) found that greater awareness of HPV correlates with 
greater knowledge of HPV, and greater knowledge of HPV correlates with vaccination 
compliance. Navalpakam et al. also found that of the participants—those more 
knowledgeable of HPV—felt the HPV vaccine should be recommended to female 
patients by their gynecologist. These participants also believed they would recommend 
the HPV vaccine to their friends. The students’ knowledge of HPV increases awareness 
of HPV vaecination rates. Similar to Navalpakam et al.’s results, the current researehers 
found that participants with higher levels of vaccination status and participants who had 
received more shots of the series scored higher on the HPV knowledge questions of the 
survey.
When looking at the different levels within the factor of age, the partieipants ages 
18-22 years were more knowledgeable of HPV and HPV-related diseases than those ages 
23-26 years. There were 23 participants ages 18- to 22 years, and only 7 participants 
ages 23-26 years that participated in the current study. Since there was an unequal 
number of participants in each age group, these results may not be reliable when 
determining the knowledge among eollege students.
The current study sought to determine how knowledgeable college students ages 
18-26 years were of the HPV vaccine. The current researchers found that of the 30 
participants 20 participants received passing scores and 10 participants received failing
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scores. This indicates a passing rate of 66.7% in regard to participants’ knowledge of the 
HPV vaccine.
The current study found similarities and conflicting results regarding Licht et al.’s 
(2010) findings with disparities among African Americans. Licht et al. (2010) found that 
African Americans were less likely to be vaccinated than Caucasian participants, while 
the current study results indicated a higher vaccination compliance of African Americans 
than Caucasians with 66.7% compliance rate. The current study identified a statistically 
significant disparity in knowledge scores of HPV and the HPV vaccine among African 
Americans. While knowledge of HPV was lower among African Americans, the 
difference of the mean scores between Caucasians and African Americans was only 1.78. 
The scores between the two ethnicities regarding vaccination knowledge were relatively 
equal with a mean score of 4.84 among Caucasians and 4.10 among African Americans. 
African Americans accounted for 10 of the 30 participants in the current study.
Vaccination compliance scores were increased with a rate of 43.3% in the current 
study. Of the 13 partieipants who had reeeived vaccination, the majority had reeeived at 
least 2 or 3 shots of the 3-shot series. HPV vaccine initiation among the participants in 
the current research was at 43.3% {n = 13).
Licht et al. (2010) hypothesized that correlates of receiving the HPV vaccine, 
including knowledge, lack of awareness of HPV effects, and cervical cancer, were 
associated with lower rates of vaccine uptake. Licht et al. found that knowledge of HPV 
and its effects was not a predictor of vaccine uptake as knowledge of HPV was a 
variable. Licht et al. (2010) found that those who correctly identified HPV as a cause for 
genital warts and penile cancer were 1.85 times more likely to have received at least 1 
dose of the vaccine. However, it is not known if the participants were more
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knowledgeable due to them having received the vaccine or if more knowledge resulted in 
their vaecine uptake. Similar to Licht et al.’s (2010) findings, the current study found no 
correlation between knowledge and vaccine uptake. Looking closer at each factor and 
the correlation between knowledge and vaccine compliance, the current researchers 
found participants ages 23-26 years had a vaccine compliance score of 66.7% and HPV 
knowledge mean score of 15.71, which is considered a failing score. The participants 
ages 18-22 years had a vaccine compliance score of 44.9% with HPV knowledge mean 
score of 17.39, which is a passing score. This indicated that the younger group ages 18- 
22 years was more knowledgeable of HPV, yet they had a lower vaceine compliance.
Conroy et al. (2009) reported a vaccination rate of 36% in their study that was 
conducted 12-18 months after the vaccine was introduced. Compared to the current study 
some 10 years later, vaccination rates do not appear to be significantly increased. 
However, the smaller sample of the current study may not have yielded results that are 
generalizable to the population. Conroy et al.’s study also found that participants with 
insurance coverage were 5 times more likely to receive the vaccine. Similar to Conroy et 
al.’s findings, the current study found higher vaccine compliance rates among 
participants with private/commercial insurance (38.9%) and Medicare/Medicaid (80.0%) 
as opposed to those who were uninsured (25.0%)
Compliance was slightly increased in the current study in comparison to the 
results O’Flarity (2012) found, which was a 29.4% compliance of either initiating or 
completion of the vaccination series. Similar to O'Flarity's study, the current study found 
no statistically significant difference in the knowledge of HPV and the HPV vaccine 
among males versus females. The vaccination rate appears higher among males than
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females in the current study; however, the females of the study sample made up 86.7% of 
the participants.
The time difference of 5 years between the two studies may have played a role in 
the difference of findings. The current researchers believe more providers are informing 
at-risk populations of the dangers of HPV and its associated conditions, yet there is still 
much education to be done. If more education is provided to at-risk populations, the 
more knowledgeable they will become and hopefully can make more informed choices 
regarding compliance to the HPV vaccination series.
Limitations
Several limitations of this study should be considered. The length of time allowed 
for data collection was limited. The data were gathered over a 4-week timeframe in a 
student health center that does not see a high volume of patients. This resulted in 30 
surveys being completed as opposed to the 100 surveys the researchers hoped to gather. 
Due to the small sample size of 30 participants, the study may not be a reliable indicator 
of how knowledgeable college students ages 18-26 years are of HPV, HPV-related 
diseases, and the HPV vaccination series.
The current researchers became aware of a limitation that may have resulted in 
inaccurate results. The questions assessing knowledge on the survey had the options of 
true ov false without an option of I  don’t know. This increased the possibility of the 
participants marking the right answer by guessing rather than giving an answer that 
actually revealed their knowledge.
Also, the fact that there was less diversity among the participants surveyed did not 
prove a relation to knowledge of HPV, HPV-related disease, and HPV vaccination series 
and certain demographics, such as age, gender, and race.
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The survey also relied on self-reported data and could not be independently 
verified. Vaccinated participants were asked to recall the number of vaccinations they 
were given of the 3-dose series. Since recall was used, their responses could have been 
influenced depending on the amount of time that had passed since they were given the 
vaccinations.
This study was also limited by the fact that the participants were enrolled in a 
higher education setting and, therefore, may not be representative of all individuals in the 
age group 18 to 26 years. Educated individuals may score higher due to greater access to 
health information compared to non-educated individuals that may have limited access to 
this information. This factor could restrict the generalizability of the results.
Conclusions
The current researchers concluded the majority of participants were sexually 
active females ages 18-22 years with commercial insurance coverage. Of the 30 
participants, 60% were knowledgeable of the HPV and HPV-related diseases. In 
addition, 66.7% of the participants were knowledgeable of the HPV series. Despite this 
knowledge, 50% of the participants had not taken the HPV vaccination. Although the 
participants had a minimum of a high school education, were considered adults, a 
majority had insurance and knowledge of the HPV and HPV-related diseases, and means 
for prevention, only half had taken measures to avoid contracting this preventable 
disease.
Implications
The findings of this research project indicated several implications for education 
and nursing theory. The discrepancy between knowledge and behavior is particularly 
concerning for advanced praetice nursing in a collegiate setting.
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Nursing education. The lack of vaccine uptake has far-reaching implications for 
health education as provided by nurses. Although over 60% of the study's participants 
claimed to have knowledge of the HPV and HPV-related diseases, their behavior most 
likely indicates otherwise since only half of those surveyed had taken measures to 
prevent the disease by vaccination. Because education of the patient and community is 
an essential duty of the nurse, the information obtained in this study will aid nurse 
practitioners in the student health center to develop specific strategies for educating 
students on HPV and the HPV vaccine on campus. The survey results may also be useful 
for nurses planning educational campaigns at other college campus health centers, local 
health departments, or private elinics. Advanced practice nurses have an ethical 
obligation and professional responsibility to promote healthy lifestyles, wellness 
maintenance, and illness prevention. Nursing professionals can provide these patients 
with accurate information and direction on promoting healthy lifestyles centered on their 
personal health behaviors.
Nursing theory. Implications for theory show that Pender’s Health Promotion 
Model was useful and appropriate in guiding this study. Studying health and social 
behaviors of college students ages 18-26 years, along with supportive and preventative 
measures, will help increase awareness of this preventable disease. Pender states that 
patients and primary care providers are more likely to participate in behavior if they see a 
benefit (Pender, 2011). Because patients (college students) were not able to see the 
results immediately that prevent future HPV and HPV-associated diseases, the urgency 
for prevention was missing. For this study, the knowledge of HPV, the HPV vaccination 
series, and vaccination compliance for this disease was examined with the hopes of 
raising awareness of HPV and prompting college students to seek information that will in
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turn improve health-promoting behaviors, such as vaccination as a preventive measure 
against HPV.
Further research of HPV may need to focus on more overt vaccine promotion.
The current study added to the body of research already collected on this highest risk 
group. Assessment of current vaccination rate and variables studied allowed for 
comparison of findings among age groups, gender, insurance status, and ethnicity. For 
preventable disease to be completely prevented, public awareness and health literacy are 
essential. The information colleeted in this study implies that knowledge alone does not 
guarantee an increase in vaccination rates in college students.
Despite the generally high levels of HPV vaccine acceptability among young 
adults, vaccine uptake in this population remains low. Education is an essential duty of 
the primary care provider and is needed to increase the HPV vaccination uptake rate. 
Primary care providers use education as a tool to convey pertinent information to patients 
regarding health and health maintenance and are uniquely positioned to increase the 
awareness of the benefits of undergoing the HPV vaccination. The current research 
assisted in the education of primary care providers and the general public on the 
significance of the HPV vaccination in preventing the HPV virus and the cancers 
associated with it. While knowledge alone may not produce the desired effect of 
increased vaccination rates, it is an important first step toward adopting any healthy 
behavior. This study contributed to education by assessing college students’ knowledge 
of HPV and the HPV vaccine and identifying trends among the demographic variables. 
The study findings can identify both target topics and target populations for education 
campaigns aimed at improving vaccination. The implication is that a more focused 
campaign is needed, perhaps focusing on visual representations of the associated cancers.
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Recommendations
Based on the results of the current research, the following recommendations were 
generated:
1. The primary care provider should be more active in promoting the vaccine to 
the at-risk population by consistently offering information about HPV and 
HPV vaccines at each visit by the at-risk population.
2. The primary care provider should increase public awareness of HPV and the 
HPV vaccines by using visual representations of the associated cancers during 
the aetive promotion of the vaccine.
3. Replicate the current research on a larger scale using a larger population and 
larger geographical area to determine if education on HPV vaccine and 
percentages of vaccine uptake are similar across the country.
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We are a group of graduate students in the Family Nurse Practitioner program at MUW, 
and we are collecting data for our research project. The focus of our project is the human 
papillomavirus, also known as HPV. The purpose for our research is to find out more 
about college students’ knowledge of the human papillomavirus, the human 
papillomavirus vaccine, and their adherence with the human papillomavirus vaccination 
series.
Students (like yourself) at MUW, who visit the campus clinic and are ages 18-26 years, 
will be asked to participate. If you agree to participate in this research, you will be asked 
to complete an anonymous survey, which may take about 10-15 minutes to complete. In 
order to help protect your privacy, we ask you please DO NOT put your name or any 
identifiable information on this survey. When you complete this survey, please 
RETURN it to the clinic receptionist sealed in the envelope provided.
The survey is part of a student research project and is not part of your 
routine medical history.
There will be some questions asking you about your sexual history that may evoke 
emotional discomfort. If you have any concerns or questions, please feel free to ask your 
healthcare provider at the clinic. Participation in this study is entirely voluntary, and you 
may withdraw at any time without consequence.
Completing the survey implies your consent to participate. Your participation in this 
research may not have a direct benefit to you at this time; however, the researchers may 
be able to collect information that will assist health professionals to better understand the 
knowledge barriers that may exist in college students and their vaccination compliance.
You must be ages 18-26 years and a current college student at MUW to complete 
this study.
As with any data collection, a breach of confidentiality is always possible. To minimize 
this risk, we ask no personal or identifiable information be given. Please place the 
completed survey in the envelope provided and seal it to ensure confidentiality. Please 
return the envelope to the receptionist to be picked up by the researchers.
The envelopes will only be opened by members of the research team. If you have any 
questions or concerns, please feel free to contact the lead research investigator, Jenny 





Thank you for taking the time to complete this survey.
This survey is part of a graduate research project evaluating college students’ knowledge 
of human papillomavirus (HPV), knowledge of the HPV vaccine and compliance with 
the vaccine series. Your honest answers are very important and will remain confidential. 
Thank you for taking your valuable time to complete this survey!
Demographic Information: Your answers here are helpful and confidential but are not 
required.
Current Age (years):
□  18 years to 22 years 
Gender:
□  23 years to 26 years
□  Male
Current year in college:
□  Freshman
□  Senior 
Ethnicity:
□  Caucasian (White)
□  African American (Black) 
Health Insurance Status:







□  Private or commercial insurance
□  CHIP
Sexual History:
Have you ever been sexually active? □  Yes □  No
Are you currently sexually active? □  Yes □  No
69
If you answered yes to either question above, is the number of partners 2 or more?
□  Yes □  No
Vaccination Status:
I have taken the human papillomavirus vaccination. □  Yes □  No 
If you answered yes to the ahove question, how many shots have you taken?
□  One □  Two □  Three
Questions: Please mark the True or False box. Please only select one box.
There are many different types of HPV.
□  True □  False
Antibiotics can cure HPV.
□  True □  False
Only men can get HPV.
□  True □  False
Only women can get HPV.
□  True □  False
Some types of HPV cause cervical cancer.
□  True □  False
HPV can cause genital herpes.
□  True □  False
HPV infection can cause ovarian cancer in women.
□  True □  False
Most people with genital HPV have visible signs and symptoms.
□  True □  False
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HPV is the least common sexually transmitted infection in the United States.
□  True □  False
A pap test (Pap smear) is used to find pre-cancerous cells on the cervix.
□  True □  False
HPV vaccine can only be taken after the age of 18 years.
□  True □  False
Based on my lifestyle, I helieve that I am susceptible for the HPV infection.
□  True □  False
I believe that contracting HPV is serious and life-threatening.
□  True □  False
I believe that the current HPV vaccine can prevent cervical cancer.
□  True □  False
Using a condom helps prevent HPV.
□  True □  False
There is a vaccine for women that prevents certain types of HPV.
□  True □  False
There is a vaccine for men that prevents certain types of HPV.
□  True □  False
HPV can cause abnormal Pap smears in women.
□  True □  False
HPV can affect a woman’s ability to get pregnant.
□  True □  False
HPV positive pregnant women can pass the virus to their babies.
□  True □  False
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HPV can cause genital warts.
□  True □  False
HPV is spread on toilet seats.
□  True □  False
Transmission of HPV can occur through sexual contact with another person.
□  True □  False
The HPV vaccine is available for men and women.
□  True □  False
HPV can cause oral/pharyngeal cancer.
□  True □  False
HPV can cause penile cancer.
□  True □  False
HPV can cause anal cancer.
□  True □  False
HPV is a virus.
□  True □  False
The HPV vaccine is only for people who are sexually active.
□  True □  False
HPV is curable.
□  True □  False
To ensure confidentiality, please place this completed survey in the envelope provided 
and seal it prior to returning to the health center receptionist.
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APPENDIX D 
Consent of Student Health Center
February 20, 2017
Mississippi University for Women 
1100 College Street 
Columbus, MS 39701
SUBJECT: Permission to Participate in a Research Project
We are graduate students in the Family Nurse Practitioner program at Mississippi 
University for Women in Columbus, MS. As a program requirement, we are conducting 
a voluntary, anonymous survey to evaluate how knowledge of college students, 18-26 
years of age, are of the human papillomavirus, the human papillomavirus vaccine, and 
their vaccination compliance. The students that are participating in this project are Jenny 
Edwards, Shelley Hamblin, Beverly Livingston, Julie Sparks Russell, Katy Waters, and 
Brenda Watson.
Your participation will involve granting us the privilege of having your receptionist 
distribute an anonymous survey to college students ages 18-26 years who are patients at 
the Mississippi University for Women Student Health Center, which is located on 
campus in the Eckford Building. There are three survey questions about the participant’s 
sexual history that may evolve some emotional discomfort. This has been explained in 
the informative letter that is given to participants, and they are encouraged to talk with 
their healthcare provider if a survey question makes them uncomfortable. The lead 
investigators’ and Dr. Hamill’s contact information has been provided at the end of the 
participants’ informative letter. The survey is anonymous and the participants are being 
provided an envelope to place the completed survey. The consent form that is given with 
the survey has instructions for the participant to seal the envelope before handing it back 
to the clinic receptionist. The six researchers are the only ones allowed to open the 
envelope.
If you require any information about this study or would like to speak to one of the 
researchers, please call Jenny Edwards (662-633-2032), Shelley Hamblin (662-456- 
6024), Beverly Livingston (662-719-7166), Julie Sparks Russell (662-279-9599), 
Katherine Waters (662-364-1734), or Brandi Watson (601-917-8153). You may also 
contact the chair of our research committee. Dr. Terri Hamill at (662-312-7926). In 
addition, you
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may withdraw your consent and participation in this study at any time by contacting one 
of the researchers or the chair of our research committee.
Sincerely,
Jenny Edwards, RN, BSN, FNP Graduate Student 
Shelley Hamblin, RN, BSN, FNP Graduate Student 
Beverly Livingston, RN, BSN, FNP Graduate Student 
Julie Sparks Russell, RN, BSN, FNP Graduate Student 
Katherine Waters, RN, BSN, FNP Graduate Student 
Brandi Watson, RN, BSN, FNP Graduate Student
I have read the above letter of consent and agree to the utilization of this clinic for the 
above mentioned research project. I also understand that the results of the study will be 
made available to me at the project’s end.
Name, Title, Signature Date
